speb/financial-data huggingface dataset:
BHEL.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 13308600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 11900000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Investments In Other Ventures Under Equity Method: 2544800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 0.00
BHEL.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 34230000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1514200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 235500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 235500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 2544800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 24890800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 37622500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Minority Interests: -825500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Net Debt: 70891400000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 560300000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income: 2822200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2822200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 2822200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2822200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2822200000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2426600000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 2822200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Interest Income: -3338600000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 11134900000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 34230000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -3338600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Net PPE: 27953200000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2235800000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 34230000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 243492500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 44997800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 42012600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 3058000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 10224200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Normalized Income: 1419470000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -37129000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Operating Income: 1798000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Operating Revenue: 229205200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 3482063355.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 159133800000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 40669400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 237422400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 894000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 2975300000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 2141100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 100000.00
BHEL.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 271500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 3722000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Payable: 17430100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Properties: 10017900000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 143290900000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 37396500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Other Special Charges: -2015300000.00
BHEL.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Payables: 102841300000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 5195600000.00
BHEL.NS income_statement (annual, 2024-03-31) — Pretax Income: 2426600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
BHEL.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -11881800000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2325000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 32839700000.00
BHEL.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 168071100000.00
BHEL.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2489000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 576000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 576000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Research And Development: 234400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 6989600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -63901500000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 11134900000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 89200000.00
BHEL.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 2030300000.00
BHEL.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 3979000000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Share Issued: 3482063355.00
BHEL.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 34230000000.00
BHEL.NS income_statement (annual, 2024-03-31) — Special Income Charges: 2015300000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 244386500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 243492500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 601170000.00
BHEL.NS income_statement (annual, 2024-03-31) — Tax Provision: -395600000.00
BHEL.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
BHEL.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 15300400000.00
BHEL.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 2221700000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Assets: 590019200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 244386500000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Debt: 88564600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 244386500000.00
BHEL.NS income_statement (annual, 2024-03-31) — Total Expenses: 227407200000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 345632700000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 244598100000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 93160300000.00
BHEL.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 963900000.00
BHEL.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 2003900000.00
BHEL.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 2003900000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 22927600000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Trading Securities: 0.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Work In Process: 39177400000.00
BHEL.NS balance_sheet (annual, 2024-03-31) — Working Capital: 92948700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 87974000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 64927400000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1680700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 630100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 6964100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 7209300000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 53964300000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 6964100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 241989700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 3108200000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 371639300000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 259200000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 90646500000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 90905700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 269652900000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 30565800000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 894700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 27919100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 81613000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 332636200000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1680700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 370900000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 370900000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 2653600000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 21056800000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 83437200000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 27919100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 241095000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 42620600000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 3482063355.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 169288400000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 47159100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 235025600000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 894700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 144989800000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 62075800000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 24810900000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 46755000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Payables: 87974000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 3482063355.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 241989700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 241095000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 1846200000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 617925100000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 241989700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 91276600000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 241989700000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 375935400000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 246285800000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 106282500000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 18853000000.00
BHEL.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 101986400000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 24565500000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 72770900000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 3453846154.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.39
BHEL.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 45841800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 678800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 678800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 3453846154.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.39
BHEL.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — EBIT: 3625300000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — EBITDA: 4304100000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 26929100000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 1837800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1837800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -1837800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1837800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 4304100000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 1347000000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Operating Income: 2363600000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 72770900000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1079100000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 9066400000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1787500000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 45841800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 678800000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 440500000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
BHEL.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 70407300000.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BHEL.NS income_statement (annual, 2025-03-31) — +Operating Expense: 77019000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 22934400000.00
BHEL.NS income_statement (annual, 2025-03-31) — +Total Revenue: 273551700000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 89933700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 95409200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 95409200000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 58843500000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 58843500000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -45420100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -45420100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 378700000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 378700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -13753600000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -13753600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Amortization: 208300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 208300000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 7159500000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 7159500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 3482100000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3478965517.00
BHEL.NS income_statement (annual, 2025-03-31) — Basic EPS: 1.53
BHEL.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.45
BHEL.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 18350400000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 21322800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 21322800000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3043700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 2196000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2196000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 6964100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 3903200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3903200000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 70083800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 70083800000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -874400000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 18800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 18800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 3884400000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 3884400000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -26325300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 79272500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Change In Payable: 8469400000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -44116000000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 17300600000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -13958300000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Common Stock: 6964100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 6964100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 247221800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 247221800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1663600000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1663600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 188451500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 59532700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Assets: 427597700000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 427597700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 572100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 572100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Debt: 87950000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 87950000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 88522100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 88522100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 282255900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 282255900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 18153100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 18153100000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Depreciation: 2511300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2719600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2719600000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 850200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2511300000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 850200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 3482100000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3478965517.00
BHEL.NS income_statement (annual, 2025-03-31) — Diluted EPS: 1.53
BHEL.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.45
BHEL.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 5044500000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 13500000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 13500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 380800000.00
BHEL.NS income_statement (annual, 2025-03-31) — EBIT: 14938600000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — EBIT: 9058500000.00
BHEL.NS income_statement (annual, 2025-03-31) — EBITDA: 17658200000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — EBITDA: 9908700000.00
BHEL.NS cash_flow (annual, 2025-03-31) — End Cash Position: 4392100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
BHEL.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -8568100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 6059000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6059000000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 18881000000.00
BHEL.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 2671700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1180000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1180000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 72597100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 72597100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 75708200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 75708200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Gross Profit: 85100200000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 30401000000.00
BHEL.NS income_statement (annual, 2025-03-31) — Interest Expense: 7482600000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 2014300000.00
BHEL.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 7482600000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2014300000.00
BHEL.NS income_statement (annual, 2025-03-31) — Interest Income: 4026300000.00
BHEL.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 4026300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -7082500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 3717400000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Inventories Adjustments Allowances: -7657700000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -7657700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Inventory: 98694900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 98694900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 335171800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 335171800000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -27314900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 4500000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 4500000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Investments In Other Ventures Under Equity Method: 2755700000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 2755700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1520600000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1520600000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 1623900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1623900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1623900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1623900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 2755700000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 2755700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 25855600000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 25855600000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 39090900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 39090900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
BHEL.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Net Debt: 84046800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 84046800000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -169700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income: 5044500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 5044500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 5044500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5044500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5044500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 7456000000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 5339000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 5044500000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Interest Income: -5034500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -2014300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -28726500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -130000000.00
BHEL.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -5034500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2014300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 72400000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 222500000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Net PPE: 30288100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 30288100000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2909100000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -130000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 246041800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 246041800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 102070100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 102070100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 40677200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 40677200000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 3437200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 3437200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 15537500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9908700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Normalized Income: 3820435447.96
BHEL.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 5044500000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 21924700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Operating Income: 8081200000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Operating Income: 7466600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Operating Revenue: 273551700000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 89933700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 3482063355.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3482063355.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 189553900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 189553900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 67766300000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 67766300000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 240257500000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 240257500000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1180000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1180000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 3049800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 3049800000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 3186800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -200000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 344700000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1492700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 17032100000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 6690600000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Payable: 16127100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 16127100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Properties: 12110300000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 12110300000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 169340800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 169340800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 66180600000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 66180600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Other Special Charges: -2063100000.00
BHEL.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Payables: 111549800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Payables: 111549800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 6697100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6697100000.00
BHEL.NS income_statement (annual, 2025-03-31) — Pretax Income: 7456000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 7044200000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BHEL.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -8791300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
BHEL.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -28784100000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -3043700000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 43548900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 43548900000.00
BHEL.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 188451500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 59532700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2719600000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 850200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 627400000.00
BHEL.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 627400000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -130000000.00
BHEL.NS income_statement (annual, 2025-03-31) — Research And Development: 273200000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 6040300000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 6040300000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -59432900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -59432900000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 57600000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 134600000.00
BHEL.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 2465300000.00
BHEL.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 5137000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Share Issued: 3482063355.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 3482063355.00
BHEL.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -130000000.00
BHEL.NS income_statement (annual, 2025-03-31) — Special Income Charges: 2063100000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 247221800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 247221800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 246041800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 246041800000.00
BHEL.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 602135447.96
BHEL.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BHEL.NS income_statement (annual, 2025-03-31) — Tax Provision: 2117000000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 1999700000.00
BHEL.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.28
BHEL.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.28
BHEL.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 17897300000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 17897300000.00
BHEL.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 812900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Assets: 680831800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 680831800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 247221800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 247221800000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Debt: 90146000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 90146000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 247221800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 247221800000.00
BHEL.NS income_statement (annual, 2025-03-31) — Total Expenses: 265470500000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 82467100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 433610000000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 433610000000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 253234100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 253234100000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 151354100000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 151354100000.00
BHEL.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 1578200000.00
BHEL.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 2120700000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BHEL.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 2120700000.00
BHEL.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 21707900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 21707900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Trading Securities: 0.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Trading Securities: 0.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Work In Process: 53694900000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 53694900000.00
BHEL.NS balance_sheet (annual, 2025-03-31) — Working Capital: 145341800000.00
BHEL.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 145341800000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 22120300000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 54869100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3477099237.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -1.31
BHEL.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 38865400000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 745200000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 745200000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3477099237.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.31
BHEL.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — EBIT: -4268300000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — EBITDA: -3523100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 16003700000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1812100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1812100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1812100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1812100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3523100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -4555000000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Operating Income: -6116600000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 54869100000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1711600000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6750500000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -6080400000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 38865400000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 745200000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -1525400000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
BHEL.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 60985700000.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 21433900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 84731000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3485714286.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.12
BHEL.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 58624000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 779900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 779900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3485714286.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.12
BHEL.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — EBIT: 7023000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — EBITDA: 7802900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 26107000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1824700000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1824700000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1824700000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1824700000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7802900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 3904000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Operating Income: 4673100000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 84731000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2187500000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 5346900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 5198300000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 58624000000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 779900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1294300000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
BHEL.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 80057900000.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
BHEL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BHEL.NS income_statement (annual, 2026-03-31) — +Operating Expense: 77739000000.00
BHEL.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 26245300000.00